Jeff Hansen

Jeff Hansen

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Editor

jeffhans@uab.edu | (205) 209-2355

Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.

Specific beats: 

  • Alabama Drug Discovery Alliance
  • Biochemistry and Molecular Genetics 
  • Biomatrix Engineering and Regenerative Medicine 
  • Cell biology 
  • Center for Biophysical Sciences and Engineering 
  • CCTS
  • Center for Metabolic Bone Disease 
  • Microbiology 
  • Neurobiology 
  • Comprehensive Neuroscience Center 
  • Pathology, research shared with MS2
  • Pharmacology and Toxicology 
  • Physiology and Biophysics 
  • UAB Research Foundation/IIE 
  • Research Administration

Brown to lead $2.8 million NSF grant to create an undergrad research administration curriculum

Brown to lead $2.8 million NSF grant to create an undergrad research administration curriculum
The grant will develop a credentialed curriculum for a career path in research administration and grants management.

COPD and BPD: Inhalation of live Lactobacilli lessens lung inflammation and improves lung function

COPD and BPD: Inhalation of live Lactobacilli lessens lung inflammation and improves lung function
This live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression.

NIH grant establishes UAB’s Global Research Resource for Human Tuberculosis

NIH grant establishes UAB’s Global Research Resource for Human Tuberculosis
Goal of this UAB-led service is transforming the global landscape of TB research through accelerated study of human TB tissue.

Memory loss in aging and dementia: Dendritic spine head diameter predicts memory in old age

Memory loss in aging and dementia: Dendritic spine head diameter predicts memory in old age
This finding suggests that therapy to remodel synapses could help memory in old age and dementia patients.

Type 1 diabetes: UAB startup gains FDA clearance to test novel oral drug

Type 1 diabetes: UAB startup gains FDA clearance to test novel oral drug
The novel drug TIX100 functions differently from any approved diabetes drug to promote proper islet cell function.

Tiny deletion in heart muscle protein briefly affects embryonic ventricles but has long-term effects on adult atrial fibrillation

Tiny deletion in heart muscle protein briefly affects embryonic ventricles but has long-term effects on adult atrial fibrillation
These findings in zebrafish and human heart muscle cells have clinical implications for patients with atrial fibrillation.

Landmark drug trial shows promising results for Pitt-Hopkins syndrome

Landmark drug trial shows promising results for Pitt-Hopkins syndrome
This devastating neurodevelopmental disorder has no currently approved treatments.

Deep machine-learning speeds assessment of fruit fly heart aging and disease, a model for human disease

Deep machine-learning speeds assessment of fruit fly heart aging and disease, a model for human disease
Use of high-speed video microscopy and artificial intelligence provides calculated statistics like diastolic and systolic diameters, fractional shortening, and ejection fraction.

$18.5 million U19 grant will study B and T memory cells in transplanted lungs, uteruses and kidneys

$18.5 million U19 grant will study B and T memory cells in transplanted lungs, uteruses and kidneys
Indirect benefits could include how to lessen rejection of transplanted organs and damage to the transplanted tissue.

Encouraging Phase 1 data for glioblastoma treatment reported by UAB researchers at ASCO

Encouraging Phase 1 data for glioblastoma treatment reported by UAB researchers at ASCO
Ninety-two percent of evaluable patients treated with INB-200 exceeded a median progression-free survival of seven months. Glioblastoma multiforme is the most aggressive type of cancer originating in the brain.
Page 1 of 51